In addition, the same authors identified a molecular signature, comprising also EFNA1, PTPN12, ATF2 and mir-26b and mir-200, that was of prognostic significance in patients with stage I–III CRC and proposed it as a novel CRC prognostic biomarker [50]. The gene discussed is PTPN12; the disease is colorectal carcinoma.